SKI Market

Indian Indices

Sensex

83,246.18 -324.17
( -0.39%)

Global Indices

Nasdaq

49,379.59 -83.86
(-0.17%)

Dow Jones

6,960.70 -4.77
(-0.07%)

Hang Seng

53,565.61 -370.56
(-0.69%)

Nikkei 225

10,219.48 -19.46
(-0.19%)

Forex

USD-INR

90.32 0.07
(0.08%)

EUR-INR

104.98 -0.13
(-0.12%)

GBP-INR

121.10 -0.20
(-0.16%)

JPY-INR

0.57 0.00
(0.21%)

YOU ARE HERE :
HOME
Markets
Equity
Company News Details

EQUITY - MARKET SCREENER

Accent Microcell Ltd

Industry : Pharmaceuticals - Indian - Bulk Drugs & Formln

BSE Code

ISIN Demat

Book Value()

92465

INE0Q5D01013

97.7797217

NSE Symbol

P/E(TTM)

Mar.Cap( Cr.)

ACCENTMIC

25.22

833.62

EPS(TTM)

Face Value()

Div & Yield %

13.78

0.29

Back

Choksi Asia standalone net profit rises 107.69% in the September 2025 quarter

Nov 13,2025

Net profit of Choksi Asia rose 107.69% to Rs 1.35 crore in the quarter ended September 2025 as against Rs 0.65 crore during the previous quarter ended September 2024. Sales rose 57.84% to Rs 13.29 crore in the quarter ended September 2025 as against Rs 8.42 crore during the previous quarter ended September 2024.

Particulars	Quarter Ended
	Sep. 2025	Sep. 2024	% Var.
Sales	13.29	8.42	58
OPM %	12.04	11.40	-
PBDT	1.75	1.07	64
PBT	1.67	1.03	62
NP	1.35	0.65	108

83,246.18 -324.17 ( -0.39%)

49,379.59 -83.86 (-0.17%)

6,960.70 -4.77 (-0.07%)

53,565.61 -370.56 (-0.69%)

10,219.48 -19.46 (-0.19%)

90.32 0.07 (0.08%)

104.98 -0.13 (-0.12%)

121.10 -0.20 (-0.16%)

0.57 0.00 (0.21%)